Mirzotamab clezutoclax
目录号 : KM37763
CAS No. : 2229859-12-3
Mirzotamab clezutoclax (ABBV-155) 是一种首创的抗体药物偶联物 (ADC),由三种成分组成:抗 B7-H3 单克隆抗体和 BCL2L1 (BCL-XL) 抑制剂 Clezutoclaxum 。Mirzotamab clezutoclax 可用于复发和/或难治性 (R/R) 实体瘤的研究。
Other Forms of Rapamycin:
KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
KKL 顾客使用本产品发表的 0 篇科研文献
暂无科研文献
| 生物活性 |
Mirzotamab clezutoclax (ABBV-155) is a first-in-class antibody-drug conjugate (ADC) with three components: an anti-B7-H3 monoclonal antibody, and BCL2L1 (BCL-XL) inhibitor Clezutoclaxum . Mirzotamab clezutoclax can be used for the study of relapsed and/or refractory (R/R) solid tumors.
|
| CAS号 |
2229859-12-3
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere.
|
| 储存方式 |
| Powder |
-20°C |
3 years |
| |
4°C |
2 years |
| In solvent |
-80°C |
6 months |
| |
-20°C |
1 month |
|